baber/WOPTO huggingface dataset:
Patent NZ-544334-A (NZ)
Title: A swimming pool cleaning and sanitising system using simultaneous ionization, ultrasonic cleaning and electronic oxidation
Inventor: STUTT GARY ARTHUR
IPC: C02F1/467
Filed: 2004-05-21
Abstract: A cleaning and sanitation apparatus for cleaning a liquid, the apparatus comprising ionization means to produce ions having an algaecidal or bactericidal effect into the liquid, ultrasonic cleaning means to introduce sound waves into the liquid, and electronic oxidation means to increase the oxidation reduction potential of the liquid, wherein the ionization means, the ultrasonic cleaning means and the electronic oxidation means are operated simultaneously for a period to clean and sanitise the liquid in the absence of added salt, chlorine or other chemicals. Water from the pool enters the system and is moved around the system by a pump (11). The pump moves the water from the intake pipe (12) into a filter (13). The filter is designed to remove material such as undissolved particulates, leaves or sticks, from the liquid stream. The water may then proceed through a heater (14) or similar apparatus, if the pool is a heated type pool. From the heater, the water proceeds through an electrolytic cell (15). The electrolysis cell is generally used according to the salt water chlorination process. From the electrolysis cell, the water proceeds back to the pool. The system is controlled by a control system (16) which generally houses the power pack. The system is fitted with a timer (17) to control the cycle time. The electrolysis cell and the filter are connected to the same power source.
Patent NZ-547733-A (NZ)
Title: UV-stable, liquid or semi-solid transdermal administration form comprising a photosensitive active ingredient
Inventor: PODHAISKY HANS-PETER
IPC: A61K47/32
Filed: 2004-12-06
Abstract: Provided is a semisolid or liquid transdermal administration form as a hydroalcoholic gel, characterized in that it contains: i) a gestagen, estrogen or androgen as a UV photosensitive pharmaceutical active ingredient; and ii) at least one UV absorber without pharmacological activity and a molar mass of greater than 250 gmol-1 , wherein the UV absorber is present dissolved or dispersed in the administration form and the UV absorber is selected from the group which comprises p-aminobenzoic acid and aminobenzoic acid derivatives, 3-benzylidenebornan-2-one and benzylidenebornan-2-one derivatives, polymers of N-[2(and 4)-(2-oxoborn-3ylidenemethyl)benzyl]acrylamide, salicylic acid derivatives, 2,4,6-trianiline-p-[carbo-2'ethylhexyl-1'-oxy)-1,3,5-triazine, dioctyl butamido triazine, bisethylhexyloxyphenol, methoxyphenyltriazine, 3-imidazol-4-ylacrylic acid, 2-phenylenebenzimidazole-5-sulfonic acid and its K, Na and triethanolamine (= TEA) salts, 2,2'-(1,4- phenylene)bis (1H-benzimidazole-4,6-disulfonic acid, monosodium salt), methylenebisbenzotriazolyltetramethyl-butylphenol, drometriazole trisiloxane, 2-cyano-3,3-diphenylacrylic acid, terephthaloylidene-dicamphorsulfonic acid, butylmethoxydibenzoylmethane, and benzophenones or benzophenone derivatives.
Patent NZ-551015-A (NZ)
Title: Glucagon receptor antagonists, preparation and therapeutic uses
Inventor: CONNER SCOTT EUGENE
IPC: A61K31/197
Filed: 2005-06-08
Abstract: Disclosed are compounds of formula (I), wherein Y is O or S and the remaining substituents are as defined in the specification, as well as methods for preparing such compounds. The compounds are glucagon receptor antagonists or inverse agonists useful in treating diabetic and other glucagon related metabolic disorders.
Patent NZ-554720-A (NZ)
Title: Compositions and uses of fingolimod (2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol)
Inventor: KOVARIK JOHN M
IPC: A61K31/133
Filed: 2005-11-28
Abstract: Disclosed is the use of a S1P receptor modulator or agonist selected from 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol (fingolimod), 2-amino-2-[4-(3-benzyloxyphenoxy)-2-chlorophenyl]ethyl-1,3-propane-diol, 2-amino-2-[4-(benzyloxyphenylthio)-2-chlorophenyl]ethyl-1,3-propane-diol or 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl- benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid, in free form or in a pharmaceutically acceptable salt form for the preparation of a medication for the inhibition of graft rejection or treatment of an autoimmune disease or disorder, wherein the medication is adapted to provide a daily dosage of said S1P receptor modulator or agonist that is increased stepwise from 4- to 12-fold the standard daily dosage of said S1P receptor modulator or agonist during the initial 3 to 6 days of treatment, such that a steady-state of the S1P receptor modulator or agonist blood levels is attained in less than a week, and wherein the standard daily dosage is the dosage necessary for a stable blood level concentration of the medication providing effective treatment. Also disclosed is a kit containing daily units of medication of an S1P receptor modulator or agonist as defined above of varying daily dosage, whereby the daily dosage of S1P receptor modulator or agonist for the initial 4 days of treatment is 1; 1.5-2; 2-3 and 3-4 fold the standard daily dosage.
Patent NZ-563614-A (NZ)
Title: Safety line anchor
Inventor: BEALE RICHARD ALAN FREDERICK
IPC: A62B1/04
Filed: 2006-04-25
Abstract: An anchor assembly for an elongate safety line is disclosed. The assembly comprises of a safety line gripping means connected to a bracket means by a releasable clamping means. The releasable clamping means comprises of a tapered clamp formed by opposed clamping surfaces defining a tapered space between them; a tapered member having profile matching the tapered space; and a clamping element urging the clamping surfaces together to clamp the tapered member between them.
Patent NZ-568773-A (NZ)
Title: Vorticity generators for use with fluid control systems where generator is part of or fixed to bonnet of valve
Inventor: BURKE JOSEPH MICHAEL
IPC: F16K1/32
Filed: 2006-10-05
Abstract: An example valve includes a valve body (302) and a fluid passage therethrough. The fluid passage includes an inlet (304) , an outlet (306) and a stagnation area (324) . The valve includes a control element (316,318) within the fluid passage to control the flow of fluid through the passage and a vortex generating structure (314) to direct a fluid within the fluid passage into the stagnation area (324).
Patent NZ-570737-A (NZ)
Title: Process for forming decorative patterns by orienting magnetic particles in flowable material, typically resin, and allowing material to solidify
Inventor: OLSON BARRY D
IPC: B29C70/64
Filed: 2007-04-24
Abstract: Flowable and typically polymeric or polymerizable material such as resins with oriented magnetic anisotropic particles typically steel is subjected to magnetic fields that reorient the magnetic particles. The material is allowed to solidify and the result is an aesthetic patterned appearance.
Patent NZ-579480-A (NZ)
Title: 2-Arylamino-quinazoline derivatives
Inventor: BAHCECI SULEYMAN
IPC: A61P35/00
Filed: 2008-03-13
Abstract: Disclosed are 2-arylamino-quinazoline derivatives as represented by the general formula (I) which modulate the Hedgehog pathway, wherein: R2 and R3 together with the pyrimidinyl to which they are attached form a quinazoline ring which is optionally substituted at the 5-, 6-, 7-, and 8-positions; R1 is alkyl, cycloalkyl, phenyl, or heteroaryl where the cycloalkyl, phenyl, and heteroaryl are optionally substituted; R40 is hydrogen or alkyl; R50 is a benzamide derivative as defined; and wherein the remaining substituents are as defined herein. Of particular importance are the compounds 4-[(4-phenylquinazolin-2-yl)amino]-N-(1,2,3,4-tetrahydroisoquinolin-7-yl)benzamide; and N-[2-methyl-5-(morpholin-4-ylmethyl)phenyl]-4-[(4-morpholin-4-ylquinazolin-2-yl)amino]benzamide. Further disclosed is a pharmaceutical composition which comprises a compound as defined above, or a single isomer thereof; where the compound is optionally as a pharmaceutically acceptable salt, hydrate, solvate or combination thereof, and a pharmaceutically acceptable carrier, excipient, or diluent; for the treatment of diseases such as cancer, and particularly for the treatment of basal cell carcinoma, medulloblastoma, rhabdomyosaracoma, pancreatic cancer, breast carcinoma, meningioma, glioblastoma, melanoma, stomach cancer, esophageal cancer, biliary tract cancer, prostate cancer, small cell lung cancer, non-small cell lung cancer, glial cell cancer, multiple myeloma, chronic myeloid leukemia, testicular cancer, ovarian cancer, and colon cancer.
Patent NZ-582709-A (NZ)
Title: Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
Inventor: CASTRO PALOMINO LARIA JULIO CESAR
IPC: A61P35/00
Filed: 2008-08-08
Abstract: Disclosed are azabiphenylaminobenzoic acid derivatives represented by general formula (I), such as 5-cyclopropyl-2-(2-phenylpyrimidin-5-ylamino)benzoic acid. Also disclosed is the use of the compounds of formula (I) for treating a pathological disease susceptible to amelioration by inhibition of dihydrooorotate dehydrogenase.
Patent NZ-586744-A (NZ)
Title: A portable structure, such as a water container, paddling pool, play pen or ball-pool which can be stored or erected
Inventor: YU TERESA
IPC: A45C7/00
Filed: 2009-01-23
Abstract: A portable structure (1), configurable between stored and erected conditions, comprises a base (4), one or more sides (5), a resilient frame (2) and one or more spacing members (6). The base (4) and the one or more sides (5) comprise a flexible material. The resilient frame (2) is located at the interface of the base (4) and the one or more sides (5). The resilient frame (2) is connected to the flexible material to provide a shape to the base (4) in the erected condition. The one or more spacing members (6) support the flexible material of the one or more sides (5) in a raised manner in the erected condition so as to form a container, bounded by the flexible material of the base (4) and the one or more sides (5). The resilient frame (2) and the one or more spacing members (6) are foldable to allow the portable structure (1) to adopt its stored condition, wherein folding of the resilient frame (2) and the one or more spacing members (6) provides energy for moving the portable structure (1) from the stored condition to the erected condition thereof. An opening (41) in the side is provided for allowing a person to enter or exit the portable structure.
Patent NZ-587542-A (NZ)
Title: Nicorandil carriers with enhanced stability
Inventor: POLI PIERO
IPC: A61K8/20
Filed: 2009-03-04
Abstract: A carrier for the moisture sensitive pharmaceutical nicorandil. The carrier comprises at least one tablet of nicorandil and a molecular sieve. The molecular sieve can be sodium aluminosilicate and has window openings from 3-8 angstroms in diameter. The carrier can be in the form of a blister pack.
Patent NZ-588512-A (NZ)
Title: Screen seal for a waste water filter assembly
Inventor: CONROY JAY RYAN
IPC: B01D33/04
Filed: 2010-10-12
Abstract: A seal (10) for preventing bypass of solids from a filter screen assembly is disclosed. The seal (10) includes an L-shaped bracket (46) and a housing that includes a channel-shaped member (34). A first panel of the L-shaped bracket (46) is inserted into a groove (26) of a belt of a filter screen assembly so as to fill that groove (26). The belt is received into a channel recess of the channel member (34) of the housing. A second panel of the L-shaped bracket (46) is fastened to side wall of the channel-shaped member (32). By securing the L-shaped bracket (46) to the channel-shaped member (32) of the housing, a track is formed for slidably engaging the belt during rotational movement. The belt's contact with the first panel of the L-shaped bracket (46) inserted into the belt's groove (26) forms a tight continuous seal.
Patent NZ-589055-A (NZ)
Title: Screw washer assembly with two washers with cooperating projections and recesses
Inventor: BURKE JOHN THOMAS
IPC: E04B1/41
Filed: 2009-07-14
Abstract: In combination a coupling plate 19, washer assembly 22 and a threaded fastener 21, the threaded fastener 21 having a head 39, with the assembly including a first washer 23 having an aperture 29 through which the threaded fastener 21 is to pass, and a surface surrounding the aperture, and to engage the plate, and a second washer 24, the second washer 24 having an aperture 34 through which the fastener 21 is to pass, the second washer 24 having a surface surrounding the aperture and positioned to abut the surface of the first washer 23 and to be urged into contact therewith upon tensioning of the fastener 21. The plate 19 has a pair of spaced apertures 50, 51 to provide for the coupling of adjacent concrete elements 16, 17. The surface of the second washer 24 extends beyond the aperture 29 of the first washer 23 when the surfaces abut. The aperture 29 of the first washer 23 is dimensioned to provide for relative movement between the washers with the washer apertures and one of the plate apertures aligned to provide for the insertion of the threaded fastener there through, with the second washer 24 located between the head 39 and the first washer 23. The surfaces have cooperating projections and recesses that inhibit relative movement between the washers when the threaded fastener is tensioned and urges the surface of the second washer against the surface of the first washer.
Patent NZ-589901-A (NZ)
Title: Medical headgear
Inventor: BLASZCZYKIEWICZ THOMAS
IPC: A42B7/00
Filed: 2009-05-29
Abstract: 589901 A medical headgear is disclosed comprising a thermoformed headgear section (526). The thermoformed headgear section includes a first skin-facing fabric layer (512), a first outer fabric layer (520) and a layer of rigid material (516) located between the skin-facing fabric layer (512) and the outer fabric layer (520). The first skin-facing fabric layer, the first outer fabric layer and the layer of rigid material are thermoformed together.
Patent NZ-593498-A (NZ)
Title: Ulipristal acetate tablets
Inventor: GAINER ERIN
IPC: A61K9/20
Filed: 2009-12-08
Abstract: Disclosed herein is a pharmaceutical tablet for oral administration comprising ulipristal acetate (17alpha-Acetoxy-11beta-[4-N,N-dimethylamino-phenyl]-19-norpregna-4,9-diene-3,20-dione) in an amount of 3 to 18 wt%, together with the following excipients: a diluent in an amount of 60 to 95 wt%, wherein the diluent may be selected from a monosaccharide, a disaccharide, a derivative polyol of a monosaccharide and hydrates thereof; a binding agent in an amount of 0 to 10 wt%, wherein the binding agent may be selected from hydroxypropyl methyl cellulose and povidone; croscarmellose sodium in an amount of 1 to 10 wt%, and magnesium stearate in an amount of 0 to 5 wt%, wt% designating an amount by weight, as a percentage of the total weight of the composition.
Patent NZ-597219-A (NZ)
Title: Novel fumarate salts of a histamine h3 receptor antagonist
Inventor: LANGEVIN BEVERLY C
IPC: A61K31/4725
Filed: 2010-06-24
Abstract: 597219 Disclosed herein are fumerate salts of a compound of formula I selected from the group consisting of: 2-(cyclohexylmethyl)-N-{ 2-[(2S)-1-methylpyrrolidin-2-yl]ethyl} -1,2,3,4-tetrahydroisoquinoline-7-sulfonamide difumarate monohydrate; 2-(cyclohexylmethyl)-N-{ 2-[(2S)-1-methylpyrrolidin-2-yl]ethyl} -1,2,3,4-tetrahydroisoquinoline-7-sulfonamide difumarate; 2-(cyclohexylmethyl)-N-{ 2-[(2S)-1-methylpyrrolidin-2-yl]ethyl} -1,2,3,4-tetrahydroisoquinoline-7-sulfonamide monofumarate; 2-(cyclohexylmethyl)-N-{ 2-[(2S)-1-methylpyrrolidin-2-yl]ethyl} -1,2,3,4-tetrahydroisoquinoline-7-sulfonamide hemifumarate; 2-(cyclohexylmethyl)-N-{ 2-[(2S)-1-methylpyrrolidin-2-yl]ethyl} -1,2,3,4-tetrahydroisoquinoline-7-sulfonamide hemifumarate dehydrate; and the use thereof in the treatment of a disease or disorder selected from the group consisting of obesity, diabetes?vigilance disorders?sleep disorders, narcolepsy Alzheimer's disease, dementia, Parkinson's disease, attention-deficit hyperactivity disorder, memory disorders, learning disorders, epilepsy, schizophrenia, moderate cognitive disorders, depression, anxiety, sexual dysfunction, dizziness?and travel sickness. Also disclosed is a process for the manufacture of the 2-(cyclohexylmethyl)-N-{ 2-[(2S)-1-methylpyrrolidin-2-yl]ethyl} -1,2,3,4-tetrahydroisoquinoline-7-sulfonamide difumarate monohydrate comprising the steps of contacting, under elevated temperature or at ambient temperature, 2-(cyclohexylmethyl)-N-{ 2-[(2S)-1-methylpyrrolidin-2-yl]ethyl} -1,2,3,4-tetrahydroisoquinoline-7-sulfonamide dissolved in a suitable solvent or in a mixture of solvents, with fumaric acid, optionally dissolved in a solvent or in a mixture of solvents; and isolating the precipitated solid.
Patent NZ-597251-A (NZ)
Title: Antibodies and immunoconjugates and uses therefor
Inventor: EBENS ALLEN J JR
IPC: A61K47/48
Filed: 2007-05-29
Abstract: Patent No. 597251 Disclosed is an antibody that binds to CD22, wherein the antibody comprises (1) an HVR-H1 comprising the amino acid sequence of GYEFSRSWMN; (2) an HVR-H2 comprising the amino acid sequence of GRIYPGDGDTNYSGKFKG; (3) an HVR-H3 comprising the amino acid sequence of DGSSWDWYFDV; (4) an HVR-L1 comprising the amino acid sequence of RSSQSRIVHSVGNTFLE (5) an HVR-L2 comprising the amino acid sequence of KVSNRFS; and (6) an HVR-L3 comprising an amino acid sequence of FQGSQFPYT.
Patent NZ-600538-A (NZ)
Title: Factory for the molding manufacture of precast concrete voussoirs for the construction of wind generator support towers
Inventor: FERNANDEZ GOMEZ MIGUEL ANGEL
IPC: B28B15/00
Filed: 2010-11-29
Abstract: Disclosed is a mobile precast concrete factory (10, 100) for the molding manufacture of precast cementitious voussoirs for the construction of wind generator support towers using passive steel or rebar-like element (s),as well as active pre-stressing steel, with or without sheaths, concrete and finishing accessories. The factory includes hoisting or crane means and concreting means. The factory also includes at least one reinforcing station, with at least one frame, for preparing cages, - at least one concreting station, with at least one steam setting mold including a main mold body, a counter mold and a steam setting canvas, for the application of one of the cages in the mold, the concreting of the mold, the setting of the concrete in the mold to form a set part and the extraction of the set part from the mold, the set part becoming a semifinished voussoir. There is at least one conditioning station for the finishing of the semi-finished voussoir and/or the application of finishing accessories to the semi-finished voussoir, and - at least one stocking area for the storage of finished voussoirs. The base of the reinforcing station, the concreting station and the conditioning station comprises a concrete slab formed directly on compacted terrain, the hoisting means are hoisting means without foundations, the mold body is divided into at least two portions attached to one another by fixing means, and the counter mold is divided into at least two portions attached to one another by fixing means. The factory additionally included pre-stressing and/or post tensioning means, including pre-stressing performance means and pre-stressing tendons.
Patent NZ-600646-A (NZ)
Title: Multi-temperature and multi-texture frozen food microwave heating tray
Inventor: JACKSON DANIEL C
IPC: F24C7/02
Filed: 2010-12-30
Abstract: A multi-temperature and multi-texture frozen food microwave heating tray includes a first integral compartment (14) defined by at least one sidewall (17) and an upwardly convex bottom (19), and a second integral compartment (12) defined by at least one sidewall (16) and a bottom (18) and comprising a microwave energy access modulating structure for one of the first and second compartments.
Patent NZ-607975-A (NZ)
Title: Compositions comprising abscisic acid and a fungicidally active compound
Inventor: PEARSON ELIZABETH
IPC: C07D231/02
Filed: 2011-10-21
Abstract: Disclosed is a method comprising applying to a useful plant, the locus thereof or propagation material thereof a combination of abscisic acid (as seen in the abstract drawing) and a fungicidally active compound, wherein the fungicidally active compound is a succinate dehydrogenase inhibitor to increase the potency. The plant may be a cereal or wheat plant and it may be at risk of an infection of Septoria tritici (Mycosphaerella graminicola). The fungicidally active compound may be isopyrazam. The disclosure also relates to compositions comprising abscisic acid and the fungicidally active compounds as well as seeds comprising the combinations.
Patent NZ-612035-A (NZ)
Title: System and method for tracking the usage of athletic equipment
Inventor: MARTIN TODD
IPC: A63K3/00
Filed: 2012-05-31
Abstract: Disclosed is a system for tracking the usage of athletic equipment for determining a maximum usage distance and/or time of the athletic equipment using a computer web-based platform. The system includes a database server (106) including a user database (112) for maintaining records of users registered to access the database server (106), and a training log server (116). The training log server (116) receives and stores data from each registered user regarding a category of athletic activity in which the registered user engaged, and receives and stores data from each registered user regarding a distance the registered user trained for a given day for each category of athletic activity. The training log server (116) then receives and stores data from each registered user regarding an amount of time the registered user trained for each category of athletic activity and calculates a time-based total distance for each category of athletic activity. A graphical representation of the calculated time-based total distances is generated and a processor (104) determines whether the user is a registered user based on the records maintained in the user database (112). The processor (104) generates a graphical user interface having a plurality of fields for entering data regarding the use of the athletic equipment used by the registered user such that at least one of the fields pertaining to the date of first use of the athletic equipment by the registered user.
Patent NZ-620206-A (NZ)
Title: Powdered composition for production of acidified milk beverage, preparation process thereof and acidified milk beverage produced therefrom
Inventor: CHHILLAR JITENDER
IPC: A23L29/262
Filed: 2011-07-27
Abstract: A powdered composition for the production of an acidified milk beverage is disclosed comprising based on the total weight of the composition a) 6-31 % of at least one stabilizer selected from the group consisting of carboxymethyl cellulose, pectin, xanthan, guar and carrageen; b) 48-87% of a milk-based ingredient, and c) 7-21 % of a food grade acid. The composition is the form of spray dried powder, and the sum of the amounts of each ingredient is equal to 100%. A process for preparing a powdered composition for the production of an acidified milk beverage, comprises preparing an aqueous composition containing a milk-based ingredient and a stabilizer selected from the group consisting of carboxymethyl cellulose, pectin, xanthan, guar and carrageen; acidifying the aqueous composition with a food grade acid under high shear conditions; and spray drying the acidified solution to powders. The amounts of each ingredients added are, based on the total weight of the spray dried powders, 6-31 % of the stabilizer, 48-87% of the milk-based ingredient and 7-21 % of the food grade acid; and the sum of the amounts of each ingredient is equal to 100%.